Intravascular Imaging may Improve Long-Term Outcomes in Complex PCI: Study
Five-year follow-up data from the RENOVATE-COMPLEX-PCI trial show that intravascular imaging–guided percutaneous coronary intervention leads to better clinical outcomes in patients with complex coronary lesions. Earlier results (median follow-up 2.1 years) demonstrated a 36% relative reduction in target-vessel failure—including cardiac death, target-vessel myocardial infarction, or clinically driven target-lesion revascularization—compared with angiography-guided percutaneous coronary intervention. In addition, target-vessel MI or cardiac death decreased by 37%, and cardiac death alone by 53%, highlighting the long-term benefit of intravascular imaging guidance.
Data regarding long-term outcomes of intravascular imaging-guided percutaneous coronary intervention (PCI) for complex coronary artery lesions, compared with angiography-guided percutaneous coronary intervention, remain limited.
The authors sought to present long-term clinical outcomes of intravascular imaging-guided percutaneous coronary intervention compared with angiography-guided percutaneous coronary intervention in patients with complex coronary artery lesions. Eligible patients with complex coronary artery lesions were randomly assigned 2:1 to undergo intravascular imaging-guided percutaneous coronary intervention or angiography-guided percutaneous coronary intervention in this prospective multicenter open-label superiority trial performed in South Korea. The primary endpoint was a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization.
Results: A total of 1,639 patients underwent randomization with 1,092 assigned to imaging-guided percutaneous coronary intervention and 547 assigned to angiography-guided percutaneous coronary intervention. At a median follow-up of 5.3 years (Q1-Q3: 4.4-6.2 years), the primary endpoint occurred in 109 of 1,092 patients (10.5%) in the intravascular imaging-guided percutaneous coronary intervention group and 78 of 547 patients (14.9%) in the angiography-guided percutaneous coronary interventiongroup (HR: 0.68; 95% CI: 0.51-0.91; P = 0.009). Cardiac death or target vessel–related myocardial infarction occurred in 78 patients (7.6%) in the intravascular imaging-guided percutaneous coronary intervention group and in 56 patients (10.7%) in the angiography-guided percutaneous coronary intervention group, clinically driven target vessel revascularization in 45 (4.4%) and 32 (6.2%), and definite stent thrombosis in 1 (0.1%) and 4 (0.7%), respectively. There were no apparent differences in procedure-related safety events between the groups.
In patients with complex coronary artery lesions undergoing percutaneous coronary intervention, intravascular imaging guidance reduced the risk of a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization at median follow-up of 5.3 years, compared to angiography guidance.
Reference:
Lee, J, Kim, O, Song, Y. et al. Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial. JACC. null2026, 0 (0) .
https://doi.org/10.1016/j.jacc.2026.01.035
Intravascular, Imaging, Improve, Long-Term, Outcomes, Complex PCI, Study, Lee, J, Kim, O, Song, Y.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.